BMRA - Biomerica, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 527.94M
Enterprise Value 327.12M
Trailing P/E N/A
Forward P/E 1-10.00
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)5.41
Price/Book (mrq)6.84
Enterprise Value/Revenue 35.25
Enterprise Value/EBITDA 6-12.81

Trading Information

Stock Price History

Beta (3Y Monthly) 2.54
52-Week Change 3-20.49%
S&P500 52-Week Change 31.52%
52 Week High 33.9400
52 Week Low 31.6000
50-Day Moving Average 33.0669
200-Day Moving Average 32.6129

Share Statistics

Avg Vol (3 month) 338.73k
Avg Vol (10 day) 332.96k
Shares Outstanding 59.67M
Float 7.47M
% Held by Insiders 129.54%
% Held by Institutions 11.13%
Shares Short (Jul 31, 2019) 423.45k
Short Ratio (Jul 31, 2019) 40.53
Short % of Float (Jul 31, 2019) 40.34%
Short % of Shares Outstanding (Jul 31, 2019) 40.24%
Shares Short (prior month Jun 28, 2019) 453.97k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/1
Last Split Date 3Apr 7, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends May 31, 2018
Most Recent Quarter (mrq)Feb 28, 2019

Profitability

Profit Margin -44.05%
Operating Margin (ttm)-44.38%

Management Effectiveness

Return on Assets (ttm)-29.16%
Return on Equity (ttm)-57.21%

Income Statement

Revenue (ttm)5.17M
Revenue Per Share (ttm)0.57
Quarterly Revenue Growth (yoy)-8.30%
Gross Profit (ttm)1.75M
EBITDA -2.12M
Net Income Avi to Common (ttm)-2.28M
Diluted EPS (ttm)-0.2590
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)917.93k
Total Cash Per Share (mrq)0.09
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.89
Book Value Per Share (mrq)0.42

Cash Flow Statement

Operating Cash Flow (ttm)-1.58M
Levered Free Cash Flow (ttm)-884.25k